The funding round was backed by Barclays Sustainable Impact Capital, Mercia Ventures, the Midlands Engine Investment Fund, and Green Angel Syndicate to fuel expansion.
"The transition to net zero emission for many sectors is not as simple as swapping from high-emitting fuels to renewables, and this is particularly true of the logistics industry. Zedify have identified that hyper-local delivery models are needed, in combination with low-carbon transport, in order to decarbonise the industry, reducing pollution within the UK’s cities."
The online ski tour operator has raised £5.6m from Mercia Ventures and Active Partners to support platform development and team growth.
"The launch of Heidi was borne out of our own frustrations as keen skiers who wanted to get away to the slopes but at a time and date to suit our own schedules. Having launched the company with limited investment and built it to its current size, we are now all set to take it to the next level. Our aim is to more than double in size in the next few years and become one of the top two ski travel operators."
Existing investor Mercia Ventures backed the seed follow on round to support product development and market expansion.
"By giving carers more time to spend with patients and access to better information, Log my Care helps improve the quality of care for those who need it most. The funding will enable us to continue scaling our business in the UK and extend the positive impact the system is making, by increasing the number of patients it looks after from 20,000 to over 100,000."
The funding round was led by Mercia Ventures with participation from NFU Mutual and private investors.
"I’m delighted that we have concluded our latest fundraise, and in doing so am able to welcome NFU Mutual to the shareholder register. The support we have received from these major institutions is a testament to the hard work and outstanding commercial progress that my team have been able to make over the last eighteen months."
Mercia Ventures and BGF led the Series A round to help the biotechnology firm commercialise its RNA sequencing technology.
"Genetic sequencing has come a long way since its inception in the 1970’s. The industry is now moving past short-read towards long-read sequencing, with long-read RNA sequencing being one of the most exciting new developments in biotechnology. We believe our solution could accelerate a new wave of biotechnology innovations. We are pleased to receive backing from some of the UK’s leading life science investors, which highlights its potential. The funding will help us to pursue our mission to reveal the unseen world of RNA and unlock exciting new applications."
